search index hum-molgen


CHI's 7th Annual HUMAN GENOME PROJECT: Commercial Implications
Cambridge Healthtech Institute (CHI) , San Francisco, CA
February 28-March 1, 2000

The scientific progress made possible by the simultaneous
development of advanced instrumentation and genomic
technologies has lead to an information-rich era in biology. The
prolific data will result in the ability to study biology at the
cellular level, while the use of DNA-array technology will be
instrumental in understanding the expression response to drug
treatment. These newly acquired tools, while powerful, also raise
questions about how the data should be used. This meeting
promises to show the utility of genomics in providing a wealth of
information that will continue to revolutionize the traditional
approaches to disease biology and the development of effective
therapeutic compounds used to improve human health.

Organized by:


Deadline for Abstracts:



Available on-line
Email for Requests and Registration:

Posted by: Jennifer Laakso   Host:
date: August 02, 1999 15:36:19
Generated by meetings and positions 2.0 by Kai Garlipp
Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany.
4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright.